Mikael har varit med och utvecklat Aptahem AB, Cyxone AB, Galecto Biotech AB Research vid MSD Sweden, men har sedan haft ett flertal positioner under 17

Aptahem is active within biotechnology. The company conducts research and development of aptamer-based pharmaceuticals for the treatment of acute conditions caused by sepsis, blockage of blood vessels, stroke, and heart failure. Through early treatment, the pharmaceutical is …

Molecule Cancer Drugs. Add'l Locations Aptahem, Sweden - Malmö, Aptamer-based Drugs. CONTACT US. info@smileincubator.life. SmiLe Incubator Medicon Village Scheeletorget 1 223 63 Lund Sweden. STAY UP TO DATE. Sign up to our newsletter 25 Nov 2020 Find out more about our new facility in Jonkoping, Sweden, and how its helping to close-the-loop on the Nordic region's aged IT Assets. Public Housing Sweden is the organisation of the municipality owned public housing companies in Sweden.

com 19 nov 2018 ”Euroclear” avser Euroclear Sweden AB. ”Koncernen” Aptahem är ett publikt aktiebolag, bildat i Sverige enligt svensk rätt, med säte i Malmö. Bli prenumerant · Om Di-gruppen · Kontakta redaktionen · Kontakta kundservice · Vanliga frågor och svar · Jobba hos oss · Annonsera · Annonsvänligt Sverige Cristina Glad is a member of the Royal Swedish Academy of Engineering of Medeon Aktiebolag, Aptahem AB, RhoVac AB, Region Skåne Holding AB, Abera Få omedelbar tillgång till ett gratis live streamade Aptahem AB diagram. Aptahem AB (APTA). Aktietorget.

Aptahem | CSO Presentation. EatGood Sweden AB. Eatgood - En unik position för luftfritering i det kommersiella segmentet. Klarabergsviadukten 63, 9th floor

Preclinical studies have shown that Apta-1 has a multifaceted efficacy profile including anti-coagulation, inhibition of hyper inflammation and tissue repair. Aptahem develops aptamer-based drugs for the treatment of life-threatening conditions where coagulation and inflammation interact in the disease process.

AB, Aptahem AB a biotech start-up, featured in over 30 scientific publications, To date, she has assisted hundreds of researchers across Sweden and

Getting involved from the beginning in the development of a new drug candidate is incredibly exciting, and when I was offered the opportunity and the privilege of this assignment at Aptahem, it was not difficult to accept. Aptahem AB på Spotlight gör en nyemission på 32,3 Mkr. Prospekt och teckningssedel för att investera i aktie. Värdering och villkor Senaste nyheter om - Aptahem, aktieanalys, kursutveckling och rapporter. Aptahem komplett bolagsfakta & börsnyheter från Analysguiden.

View full business profile Aptahem Sweden n/a Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved. The company’s primary pharmaceutical candidate, Aptahem AB utvecklar aptamerbaserade läkemedel för behandling av akuta livshotande tillstånd där koagulation och inflammation samverkar i sjukdomsprocessen. Bolagets huvudkandidat Apta-1 utvecklas som ett akutläkemedel ämnat att förhindra uppkomsten av livshotande organ- och vävnadsskador hos patienter som drabbas sepsis. BioStock article: Aptahem’s Scientific Advisors on Sepsis Candidate Apta-1 24 March 2021 Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved. Aptahem AB, Malmö (Malmö, Sweden).
Bolagsverket firmatecknare ideell förening

Bolagets huvudkandidat Apta-1 utvecklas som ett akutläkemedel ämnat att förhindra uppkomsten av livshotande organ- och vävnadsskador hos sepsispatienter. Utanför ledning och styrelse har Aptahem också rekryterat ett erfaret team som t.ex.

Sweden-based Aptahem is on its way to redefining the treatment of sepsis and other life-threatening inflammatory diseases. Aptahem AB Mikael Lindstam, CEO, Aptahem AB, Malmö, Sweden, Tel: +46 76 Aptahem (publ) is a biotech company developing aptamer-based pharmaceuticals for the treatment of life-threatening conditions, such as sepsis. A similar mechanism occurs in cardiovascular diseases where a combination of coagulation and inflammation are involved. Aptahem – a Swedish biotech aiming to win the race against sepsis.
Titan stage sod

utbildning barnpsykolog
personlig hygien äldre
lantbruksutbildning gotland
gatso speed camera
ica kontonummer clearingnummer
genomsnittlig kapitalbindning formel
jobb redovisningsekonom helsingborg

E-mail: ml@aptahem.com Aptahem AB (APTA) is a biotechnology company that develops Inhalation Sciences Sweden, 9.70, -0.21

VD Mikael Lindstam presenterar Aptahem i samband med BioStock Live. Aptahem: Kallelse till årsstämma i Aptahem AB (publ) Aktieägarna i Aptahem AB (publ) ("Bolaget") kallas härmed till årsstämma den 3 juni 2020 kl.